Results 231 to 240 of about 1,956,724 (307)
Phospholipase A2 (PLA2), a dormant enzyme, becomes lethal when activated—collapsing lungs in minutes. Our dual therapy (DOPS + varespladib) boosts survival from 0% to >90% in sepsis/ALI. A breakthrough for acute lung injury treatment. ABSTRACT This study reveals that phospholipase A2 (PLA2), normally stable and nontoxic, can be activated specifically ...
Jianyu Wang +7 more
wiley +1 more source
Drug-Related Halitosis: A Narrative Review. [PDF]
Iranitalab M, Ouanounou A.
europepmc +1 more source
A pH/ROS‐dual‐responsive injectable hydrogel, formed by dynamic boronic ester and Schiff base crosslinking, co‐delivers enoblituzumab (B7‐H3 blocker) and Cl‐amidine (NETs suppressor). Via localized intratumoral delivery, it synergistically reprograms the immunosuppressive tumor microenvironment, overcomes T cell infiltration barriers, restores ...
Huan Li +12 more
wiley +1 more source
A Case-Based Literature Review of RELA Associated Inflammatory Diseases. [PDF]
Karaçayır N +10 more
europepmc +1 more source
We established patient‐derived SWN cell lines and orthotopic PDX models that recapitulate patient pain phenotypes, alongside a novel intravital DRG imaging platform to track macrophage infiltration and neuronal pain responses. Using these models, we define HMGB1–CCL2–IL‐6 signaling crosstalk driving pain and identify EGF signaling as a key regulator of
Zhenzhen Yin +17 more
wiley +1 more source
On-target, off-tumor oral toxicities of talquetamab in heavily pretreated multiple myeloma. [PDF]
Alves FA +5 more
europepmc +1 more source
Periodontitis and respiratory infections - exploring the oral-systemic link. [PDF]
Beniwal SS +11 more
europepmc +1 more source

